102
Participants
Start Date
June 27, 2023
Primary Completion Date
January 31, 2026
Study Completion Date
January 31, 2028
Ampreloxetine
Oral tablet, QD
Placebo
Oral tablet, QD
National Taiwan University Cancer Center, Taipei
Auckland City Hospital, Grafton
Semmelweis Egyetem, Budapest
Theravance Biopharma Investigative Site, Parkville
Monash Health, Clayton
The Alfred Hospital, Melbourne
Theravance Biopharma Investigative Site, Christchurch
NYU Langone Health NYU Dysautonomia Center, New York
The Neurological Institute at Columbia University Medical Center, New York
Charité - Universitätsmedizin Berlin- Campus Mitte, Berlin
University of Belgrade Neurology Clinic, Belgrade
Astra Clinic (Clinic4U), Tallinn
Charite Universitaetsmedizin Berlin, Berlin
Medstar Georgetown University Hospital, Washington D.C.
Parkinson's Centre of Ospedale CTO, Milan
Hospital Universitario de La Princesa, Madrid
Hospital Universitario Infante Sofia Paseo Europa, Madrid
Tartu University Hospital, Tartu
Emory University, Atlanta
Centre Hospitalier Universitaire de Bordeaux Health, Bordeaux
Parkinson's Disease And Movement Disorders Center of Boca Raton, Boca Raton
SFM Clinical Research, LLC, Boca Raton
University of South Florida Ataxia Research Center, Tampa
Neurostudies, Inc, Port Charlotte
Aqualane Clinical Research, Naples
Vanderbilt University Medical Center, Nashville
Santa Chiara Hospital, Trento
IRCCS Istituto de Scienze Neurologiche di Bologna (ISNB), Bologna
University of Cincinnati Medical Center, Cincinnati
Quest Research Institute, Farmington Hills
Hospital Germans Trias i Pujol, Department of Neurology, Barakaldo
Instituto Investigación Sanitaria Biocruces, Barakaldo
Rush University Medical Center, Chicago
Theravance Biopharma Investigative Site, Tel Aviv
University of Kansas Medical Center Research Institute, Inc., Kansas City
Pia Fond. Cardinale Giovanni Panico Azienda Ospedaliera, Tricase
University of Texas Southwestern Medical Center, Dallas
Baylor College of Medicine, Houston
Movement Disorders and Autonomic Disorders Clinic; University of Utah, Salt Lake City
AOU San Giovanni di Dio e Ruggi d'Aragona, Salerno, Salerno
Movement Disorders Center of Arizona, Scottsdale
David Geffen School of Medicine at UCLA, Los Angeles
UC San Diego Movement Disorder Center, La Jolla
The Parkinson's and Movement Disorder Institute, Fountain Valley
Stanford Neuroscience Health Center, Palo Alto
Hawaii Pacific Neuroscience, Honolulu
Northshore University Health System, Glenview
Brigham and Women's Hospital (Neuromuscular Division), Boston
Massachusetts Chan Medical School, Worcester
INEBA Instituto Neurociencias Buenos Aires, CABA
Instituto Fleni, CABA
Médico/Hospital de la Policía Federal Churruca Visca, CABA
Hospital General de Agudos Jose Maria Ramos Mejía, CABA
Hospital Británico de Buenos Aires, CABA
Fundación Scherbovsky, Mendoza
Medical University of Innsbruck, Innsbruck
Universitatsklinikum Tulln, Tulln
Instituto de Neurologia de Curitiba S\C LTDA, Curitiba
Hospital de Clínicas - Universidade Federal de Minas Gerais (HC - UFMG), Belo Horizonte
Centro de Pesquisa Clínica (CPC) do Hospital das Clínicas de Porto Alegre (HCPA), Porto Alegre
Hospital São Lucas - PUCRS, Porto Alegre
University of Calgary - Health Sciences Centre, Calgary
Bispebjerg Hospital, Copenhagen
Hopital Caremeau, Nîmes
Centre d'Investigation Clinique Hôpital Pierre Paul Rique, Toulouse
Praxis Dr. Oehlwein, Outpatient Clinic, Gera
Azienda Ospedaliera Universitaria Policlinico Tor Vergata, Rome
Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome
Azienda Ospedaliera Santa Maria di Terni, Terni
Neurocentrum-Miwomed, Gdansk
Neuro-Care Sp. z o.o. Sp. Komandytowa, Katowice
Krakowska Akademia Neurologii Sp.zo.o., Krakow
Instytut Zdrowia dr Boczarska-Jedynak Sp. z o.o., Sp.k., Oświęcim
CNS-Campus Neurologico Senior, Torres Vedras
Fundació Assistencial Mutua de Terrassa, Terrassa
University Hospitals Birmingham NHS Foundation Trust, Birmingham
Barts Health, London
Autonomic Unit, National Hospital for Neurology & Neurosurgery, London
Salford Royal Hospital, Salford
Lead Sponsor
Theravance Biopharma
INDUSTRY